Davis Gates - Concepedia

Author

Davis Gates

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Anne Fuhlbrigge, Davis F. Gates, Davis Gates, Hendrik Nolte

Publications

694

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)University of Colorado Denver Vanderbilt University Medical Center Bayer (Switzerland)Clinical Research Institute

About

Davis Gates is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, asthma, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	291
2	Allergy	5	5	127
3	Allergy Medicine	4	4	105
4	Public Health	2	2	57
5	Health Sciences	1	1	17

Davis Gates

Publications

591

Citations

H-Index

Page 1

	Year	Citations
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol Georg Griesinger, Davis Gates, Paul Devroey, PLoS ONE	2016	92
Desloratadine therapy for symptoms associated with perennial allergic rhinitis Kenneth Kim, Gordon L. Sussman, Jacques Hébert, Annals of Allergy Asthma & Immunology AsthmaAllergyAllergy MedicineMedicinePharmacotherapy	2006	48
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia Antonio Arrieta, Lillian Sung, John S. Bradley, PLoS ONE	2019	46
Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol Luk Rombauts, Cornelis B. Lambalk, A. Schultze-Mosgau, Fertility and Sterility InfertilityHormonal ContraceptiveFertilityMedicinePhysiology	2015	38
Loratadine versus cetirizine: Assessment of somnolence and motivation during the workday Luis M. Salmun, Davis Gates, Martin B. Scharf, Clinical Therapeutics SleepBehavioral SciencesNeuropharmacologyMedicineLoratadine Versus Cetirizine	2000	36
Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma Hendrik Nolte, Ian Pavord, Vibeke Backer, Respiratory Medicine AsthmaDose-dependent Anti-inflammatory EffectPharmacologyPulmonary PharmacologyAllergic Rhinitis	2013	33
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, The Lancet	2025	29
Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents Robert Anolik, David S. Pearlman, Ariel Teper, Allergy and Asthma Proceedings	2009	28
Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis Eli O. Meltzer, Davis Gates, Claus Bachert Annals of Allergy Asthma & Immunology AsthmaAllergyAllergy MedicineAcute RhinosinusitisAllergic Rhinitis	2012	28
Validation and agreement across four versions of the asthma control questionnaire in patients with persistent asthma Kathleen W. Wyrwich, Sajjad Khan, Prakash Navaratnam, Respiratory Medicine AsthmaPulmonary CareAllergyClinical EpidemiologyPersistent Asthma	2010	22

Page 1